Indoximod combined with chemotherapy in newly diagnosed AML patients

Phase II trial of nivolumab combined with ibrutinib for patients with Richter transformation

Ibrutinib with obinutuzumab in patients with chronic lymphocytic leukaemia

Results of using dara-CyBorD to treat patients with newly diagnosed or relapsed multiple myeloma

Regional radiation benefits high risk breast cancer patients

Practical approach to the management of the axilla after neoadjuvant chemotherapy

Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from the phase III SOLAR-1 trial

Modulation of anti-tumour immunity using CDK4/6 inhibitors

Brain metastases developed from HER2 positive and triple negative breast cancer

Chemo-immuno combination shows improved PFS when compared with sole chemotherapy treatment in advanced breast cancer

SABCS 2018: Highlights in breast cancer treatment

Prognostic value of circulating tumour-cell count in metastatic breast cancer patients